GemVax & KAEL Co.,Ltd. Q3 operating loss of KRW 1.9 billion, turning to a loss; revenue KRW 23.4 billion
AI summary · Not investment advice
Gemvax sold KRW 23.4 billion in Q3 but lost KRW 1.9 billion from its main business, turning from profit to loss versus a year earlier.
Operating profit · 3 months
KRW -1.9 billion
Key facts
- Revenue (3 months)
- KRW 23.4 billion
- Net income (3 months)
- KRW -8.6 billion
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 18.0 billion
- Revenue (year to date)
- KRW 64.4 billion
- Operating profit (prior-year 3 months)
- KRW 722.8 million
- Operating profit (year to date)
- KRW -1.7 billion
- Net income (prior-year 3 months)
- KRW -2.5 billion
- Net income (year to date)
- KRW -20.0 billion
Commentary
AI commentary · Not investment advice
What happened
Gemvax reported its consolidated results for the 3rd quarter of 2026 in its quarterly report. Sales for the latest 3 months were KRW 23.4 billion, up 30.2% from KRW 18.0 billion in the same period a year earlier. Cumulative sales this year are KRW 64.4 billion.
In the company's terms
Operating profit (profit from the core business) for the latest 3 months was a loss of KRW 1.9 billion. A year earlier, the same period showed a profit of KRW 0.7 billion, so it turned into a loss. Cumulative operating profit this year is a loss of KRW 1.7 billion.
What changes for shareholders
Net income (the final profit after taxes and all other items) for the latest 3 months was a loss of KRW 8.6 billion. A year earlier it was a loss of KRW 2.5 billion. Cumulative net income this year is a loss of KRW 20.0 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
G